DelveInsight Business Research Press Releases

• Published on December 6, 2024 - 10:55 GMT

  Down Syndrome Market Poised for Remarkable Growth, 2024-2034 Trends by DelveInsight | Aelis Farma, AC Immune

  What contributions are Annovis Bio, Aphios Therapeutics, and others making to the Down Syndrome treatment market? LAS VEGAS , NV, UNITED STATES, December 6, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Down Syndrome Market Insights, Epidemiology, and …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 5, 2024 - 12:43 GMT

  

  S1PR Modulator Market Projected to Witness Significant Growth by 2034, Says DelveInsight

  ALBANY, NY, UNITED STATES, December 5, 2024 /⁨EINPresswire.com⁩/ -- The S1PR modulators market is expected to show a remarkable expansion, driven by advancements in pharmaceutical research and therapeutic applications. With a growing understanding of S1P …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 5, 2024 - 12:47 GMT

  Hemophilia A Market Poised for Remarkable Growth, 2024-2034 Trends by DelveInsight

  What contributions are BioMarin Pharmaceutical, Roche, Sanofi, Pfizer, and others making to Hemophilia A innovations? LAS VEGAS , NV, UNITED STATES, December 5, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Hemophilia A Market Insights, Epidemiology, and …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 5, 2024 - 12:43 GMT

  Acute Myocardial Infarction Market Poised for Remarkable Growth from the Forecast Period 2024-2034 | DelveInsight

  How are companies like Viatris, AstraZeneca, Eli Lilly and Company, and Amgen set to revolutionize the Acute Myocardial Infarction market? LAS VEGAS , NV, UNITED STATES, December 5, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight's “Acute Myocardial …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 5, 2024 - 12:43 GMT

  

  Phosphodiesterase-4 (PDE4) Inhibitor Market Projected to Grow at a Strong CAGR from 2020 to 2034 by DelveInsight

  PDE4 Inhibitor companies are Arcutis Biotherapeutics, Chiesi Farmaceutici, Verona Pharma, Eisai, vTv Therapeutics, Tetra Therapeutics, Palobiofarma, etc ALBANY, NY, UNITED STATES, December 5, 2024 /⁨EINPresswire.com⁩/ -- The Phosphodiesterase-4 (PDE4) …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 5, 2024 - 12:43 GMT

  

  Janus kinase (JAK) Inhibitor Market Projected to Grow at a Strong CAGR from 2020 to 2034 by DelveInsight

  Janus kinase (JAK) Inhibitor Companies are Eli Lilly, Incyte Corporation, Dompé Farmaceutici, Sanofi, Celgene, AstraZeneca, Karyopharm Therapeutics, etc. ALBANY, NY, UNITED STATES, December 5, 2024 /⁨EINPresswire.com⁩/ -- The JAK inhibitor market is …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 5, 2024 - 12:43 GMT

  

  Tumor necrosis factor (TNF)-alpha Inhibitor Market Will Witness Growth with Emerging Therapies by 2034 | DelveInsight

  TNF-alpha Inhibitor therapies are Remicade (Infliximab), Enbrel (Etanercept), Humira (Adalimumab), Cimzia (Certolizumab Pegol), Simponi (Golimumab), more. ALBANY, NY, UNITED STATES, December 5, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s Tumor necrosis …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 4, 2024 - 13:10 GMT

  Uveitis Market Forecast to Thrive with Emerging Therapies, 2024-2034 Study by DelveInsight

  How Do Tarsier Pharma, Oculis Pharma, Eli Lilly and Company, Eyevensys, Acelyrin, Affibody Medical, and Priovant Therapeutics Drive Progress in Uveitis Care? LAS VEGAS, NV, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Uveitis …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 4, 2024 - 13:10 GMT

  Usher Syndrome Market Poised for Remarkable Growth, 2024-2034 Trends by DelveInsight

  What Contributions are Laboratoires Théa, Nacuity Pharmaceuticals, AAVantgarde Bio Fighting Blindness Making to Usher Syndrome Innovations? LAS VEGAS, NV, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Usher Syndrome Market …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 4, 2024 - 12:30 GMT

  Corneal Edema Market Projected to Grow Substantially, 2024-2034 Analysis by DelveInsight

  The Impact of Emmetrope Ophthalmics, Trefoil Therapeutics, and Actual Eyes on Corneal Edema Treatment Landscape LAS VEGAS , NV, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Corneal Edema Market Insights, Epidemiology, and …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 4, 2024 - 10:49 GMT

  Aplastic Anemia Market Anticipated to Witness Rapid Growth from 2024 to 2034 | Insights by DelveInsight

  What impact are companies like Pfizer, Regeneron Pharmaceuticals, Gamida Cell, and Elixirgen having on the evolution of the Aplastic Anemia market? LAS VEGAS , NV, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Aplastic Anemia …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 4, 2024 - 10:44 GMT

  Intermediate AMD Market Expected to Expand Significantly, 2024-2034 Report by DelveInsight

  Exploring the Role of Novartis and Allegro Ophthalmics in Advancing Intermediate AMD Therapies LAS VEGAS , NV, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Intermediate AMD Market Insights, Epidemiology, and Market Forecast-2034 …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 4, 2024 - 06:30 GMT

  

  Complement Inhibitors Market 2034: Clinical Trials, Medication, Therapies, FDA Approvals, Companies by DelveInsight

  Complement inhibitors companies are Genentech, Ionis, Roche, AKARI Therapeutics, CARE Pharma, NovelMed Therapeutics, Omeros Corporation, and others. ALBANY, NY, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- (Albany, USA) DelveInsight's …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 4, 2024 - 06:30 GMT

  

  OX40 Ligand Inhibitors Market 2034: Clinical Trials, Medication, Therapies, FDA Approvals, Companies by DelveInsight

  OX40 Ligand Inhibitors companies include Amgen, Sanofi, Ichnos Sciences, and others. ALBANY, NY, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- (Albany, USA) DelveInsight's OX40 Ligand Inhibitors Market Insights report offers a thorough …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 4, 2024 - 06:30 GMT

  

  Opioid Kappa Receptor Agonists Market Poised for Significant Growth by 2034, Asserts DelveInsight

  Opioid Kappa Receptor Agonists companies are Fresenius Medical Care, Renal Pharma, Cara Therapeutics, Toray Industries, Torii Pharmaceutical, Sunimoto Pharma. ALBANY, NY, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- (Albany, USA) The Opioid …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 4, 2024 - 06:30 GMT

  

  Factor D Complement Inhibitor Market 2034: Clinical Trials, Medication, FDA Approvals, Companies by DelveInsight

  Factor D complement inhibitors companies working in the market are AstraZeneca, Alexion (a subsidiary of AstraZeneca), BioCryst, and others. ALBANY, NY, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- The factor D complement inhibitor market is …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 4, 2024 - 06:30 GMT

  

  PCSK9 Inhibitors Treatment Market 2034: Clinical Trials, Medication, Therapies, FDA Approvals, Companies by DelveInsight

  PCSK9 Inhibitors Companies are Sirnaomics, Vaxxinity, Novo Nordisk, AstraZeneca, Akeso Biopharma, Amgen, Innovent Biologics, Ionis Pharmaceuticals, more. ALBANY, NY, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- (Albany, USA) DelveInsight’s “ …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 3, 2024 - 14:00 GMT

  Diabetic Kidney Disease Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight

  What impact are companies like Daiichi Sankyo, Prokidney, AstraZeneca, and Palatin having on the evolution of the Diabetic Kidney Disease market? LAS VEGAS , NV, UNITED STATES, December 3, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Diabetic Kidney …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 3, 2024 - 13:30 GMT

  Pulmonary Arterial Hypertension Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight

  What impact are companies like Merck, Bristol Myers Squibb, and United Therapeutics having on the evolution of the Pulmonary Arterial Hypertension market? LAS VEGAS , NV, UNITED STATES, December 3, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Pulmonary …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 3, 2024 - 12:30 GMT

  Complicated Urinary Tract Infection Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight

  How are companies such as Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, and others influencing the Complicated Urinary Tract Infection market? LAS VEGAS , NV, UNITED STATES, December 3, 2024 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Complicated …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...